Multipurpose Prevention Technologies (MPT) Summit
MPTs are innovative products designed to deliver combinations of HIV and other sexually transmitted infection (STI) preventatives, and/or contraception. The MPT Summit seeks to [...]
The Dapivirine-Levonorgestrel Vaginal Ring for HIV Prevention and Contraception
The Issue Despite global efforts to reduce the number of new HIV infections to 500,000 by 2020, an estimated 1.3 million people became [...]
Dual Prevention Pill for the Prevention of HIV and Unintended Pregnancy
Young women worldwide are confronted with two significant health risks: unintended pregnancy and HIV infection. Oral pre-exposure prophylaxis (PrEP) is a highly effective [...]
Population Council to Determine Feasibility of Fast-Tracking Oral Contraceptive Multipurpose Prevention Technology (cMPT) Development
November 14, 2018—The Population Council has received initial funding from the Children’s Investment Fund Foundation (CIFF) to assess the feasibility of combining oral [...]
First Multipurpose Gel Designed to Prevent HIV, HSV, and HPV Simultaneously in Women and Men Advances in Clinical Trials
June 21, 2018—A new Phase I study of the Population Council’s multipurpose prevention technology (MPT) gel PC-1005, launching this week, will examine the [...]
World AIDS Day at our Center for Biomedical Research
The Population Council's Center for Biomedical Research began research on the sexual transmission of HIV in 1986. For over 35 years, the Center [...]
Highlights
Ensure sexual and reproductive health, rights, and choices The Population Council tackles intersecting inequalities that undermine rights and access to contraception, HIV [...]
2023 National Contraception Meeting
The National Contraception Meeting provides an annual update on the state of contraception research from grantees from the Contraception Research Branch (CRB) of the [...]
Are we investing in sexual and reproductive health products that people want to use?
On World Contraception Day, the importance of choice in the realm of sexual and reproductive health cannot be overstated Comprehensive sexual and reproductive [...]
The Future of the Modern Contraceptive Method Mix: Innovative Technology, User-Focused Design
FP2030 and the CTI Exchange, in partnership with Population Council, PSI, RHSC, and FHI 360, will host an exploration of innovative contraceptive technology, including [...]
Biomedical Development
Despite the increased use of modern contraception globally over the past 50 years, approximately 48% of all pregnancies are unintended and more than [...]
Products in Development
More than 170 million women around the world use contraceptives developed by the Center for Biomedical Research (CBR) or based on our technologies. Still, [...]